These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34254153)

  • 81. A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript "single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1" written by pechmann and colleagues".
    Sansone VA; Pane M; Messina S; Bruno C; D'Amico A; Albamonte E; Catteruccia M; Sframeli M; Pedemonte M; Vita G; Bertini E; Mercuri E;
    Eur J Paediatr Neurol; 2018 Jul; 22(4):729-731. PubMed ID: 29673809
    [No Abstract]   [Full Text] [Related]  

  • 82. A retrospective comparison of intrathecal morphine and epidural hydromorphone for analgesia following posterior spinal fusion in adolescents with idiopathic scoliosis.
    Hong RA; Gibbons KM; Li GY; Holman A; Voepel-Lewis T
    Paediatr Anaesth; 2017 Jan; 27(1):91-97. PubMed ID: 27878902
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Transforaminal lumbar puncture for intrathecal access: Case series with literature review and comparison to other techniques.
    Velayudhan V; Patel S; Danziger A; Grigorian A; Waite S; Efendizade A
    J Clin Neurosci; 2020 Feb; 72():114-118. PubMed ID: 31980274
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Children and young adults with spinal muscular atrophy treated with nusinersen.
    Osredkar D; Jílková M; Butenko T; Loboda T; Golli T; Fuchsová P; Rohlenová M; Haberlova J
    Eur J Paediatr Neurol; 2021 Jan; 30():1-8. PubMed ID: 33307321
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nusinersen in adult patients with spinal muscular atrophy: Observations from a single center.
    Moshe-Lilie O; Visser A; Chahin N; Ragole T; Dimitrova D; Karam C
    Neurology; 2020 Jul; 95(4):e413-e416. PubMed ID: 32665408
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Posterior Spinal Correction and Fusion Surgery in Patients with Spinal Muscular Atrophy-Associated Scoliosis for Whom Treatment with Nusinersen Was Planned.
    Machida S; Miyagi M; Saito W; Matsui A; Imura T; Inoue G; Nakazawa T; Shirasawa E; Ikeda S; Kawakubo A; Kuroda A; Yokozeki Y; Mimura Y; Uchida K; Akazawa T; Takaso M
    Spine Surg Relat Res; 2021; 5(2):109-113. PubMed ID: 33842719
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.
    Li Q
    Yonsei Med J; 2020 Apr; 61(4):273-283. PubMed ID: 32233169
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Posterior spinal fusion in patients with spinal muscular atrophy: a surgical technique to allow intrathecally inject nusinersen.
    Amico S; Scoscina D; Milazzo I; Martiniani M; Meco L; Siliquini S; Specchia N; Gigante AP
    Minerva Pediatr (Torino); 2023 May; ():. PubMed ID: 37155209
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.
    Bennett CF; Krainer AR; Cleveland DW
    Annu Rev Neurosci; 2019 Jul; 42():385-406. PubMed ID: 31283897
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study.
    Kiefer P; Kirschner J; Pechmann A; Langer T
    Orphanet J Rare Dis; 2020 Jul; 15(1):194. PubMed ID: 32727502
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effect of Discontinuation of Nusinersen Treatment in Long-Standing SMA3.
    Hiebeler M; Abicht A; Reilich P; Walter MC
    J Neuromuscul Dis; 2021; 8(4):537-542. PubMed ID: 33682724
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland.
    Modrzejewska S; Kotulska K; Kopyta I; Grędowska E; Emich-Widera E; Tomaszek K; Paprocka J; Chmielewski D; Pilch J; Pietruszewski J; Lemska A; Zawadzka M; Mazurkiewicz-Bełdzińska M
    Neurol Neurochir Pol; 2021; 55(3):289-294. PubMed ID: 33565602
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Real-World Data from Nusinersen Treatment for Patients with Later-Onset Spinal Muscular Atrophy: A Single Center Experience.
    Mendonça RH; Polido GJ; Matsui C; Silva AMS; Solla DJF; Reed UC; Zanoteli E
    J Neuromuscul Dis; 2021; 8(1):101-108. PubMed ID: 33074187
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps.
    Gidaro T; Servais L
    Dev Med Child Neurol; 2019 Jan; 61(1):19-24. PubMed ID: 30221755
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.
    Mercuri E; Darras BT; Chiriboga CA; Day JW; Campbell C; Connolly AM; Iannaccone ST; Kirschner J; Kuntz NL; Saito K; Shieh PB; Tulinius M; Mazzone ES; Montes J; Bishop KM; Yang Q; Foster R; Gheuens S; Bennett CF; Farwell W; Schneider E; De Vivo DC; Finkel RS;
    N Engl J Med; 2018 Feb; 378(7):625-635. PubMed ID: 29443664
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A Semi-Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy.
    Biliouris K; Gaitonde P; Yin W; Norris DA; Wang Y; Henry S; Fey R; Nestorov I; Schmidt S; Rogge M; Lesko LJ; Trame MN
    CPT Pharmacometrics Syst Pharmacol; 2018 Sep; 7(9):581-592. PubMed ID: 30043511
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Potential complications of posterior spine fusion and instrumentation in patients with cerebral palsy treated with intrathecal baclofen infusion.
    Segal LS; Wallach DM; Kanev PM
    Spine (Phila Pa 1976); 2005 Apr; 30(8):E219-24. PubMed ID: 15834321
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Nusinersen in the treatment of spinal muscular atrophy].
    Sinkó G; Kiss Z; Kalman B
    Ideggyogy Sz; 2018 Mar; 71(3-04):90-94. PubMed ID: 29889467
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Use of three-dimensional printing of a lumbar skeletal model for intrathecal administration of nusinersen: a brief technical report.
    Abe H; Inoue R; Tsuchida R; Azuma K; Ino K; Konishi M; Hozumi J; Sumitani M
    Reg Anesth Pain Med; 2020 Oct; 45(10):757-760. PubMed ID: 32817238
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Computed Tomography-Guided Lumbar Puncture: Advantages and Disadvantages.
    Ökçesiz İ; Dönmez H; Herdem N; Sarilar AÇ
    J Comput Assist Tomogr; 2022 Mar-Apr 01; 46(2):269-273. PubMed ID: 35081604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.